cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Iqvia Holdings Inc
18 own
17 watching
Current Price
$237.18
$-3.47
(-1.44%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
44,068.04M
52-Week High
52-Week High
256.62
52-Week Low
52-Week Low
165.75
Average Volume
Average Volume
0.68M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
62.9416
iconMarket Capitalization44,068.04M
icon52-Week High256.62
icon52-Week Low165.75
iconAverage Volume0.68M
iconDividend Yield--
iconP/E Ratio62.9416
What does the Iqvia Holdings Inc do?
Quintiles IMS Holdings, Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order to life science companies, and investment and financial sectors that deal with life science companies; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level to pharmaceutical sales organizations. This segment also provides OneKey, a reference database of healthcare professionals; real-world insights, and various cloud-based applications and related implementation services; and strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services. The Research & Development Solutions segment offers biopharmaceutical development services comprising project management and clinical monitoring, clinical trial support, and strategic planning and design services, as well as clinical trial, genomic, and bioanalytical laboratory services. The Integrated Engagement Services segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. Quintiles IMS Holdings, Inc. serves pharmaceutical, biotechnology, medical device, and healthcare companies. The company was formerly known as Quintiles Transnational Holdings Inc. and changed its name to Quintiles IMS Holdings, Inc. as a result of its merger with IMS Health Holdings, Inc. in October 2016. The company was founded in 1982 and is headquartered in Durham, North Carolina.
Read More
How much money does Iqvia Holdings Inc make?
News & Events about Iqvia Holdings Inc.
Business Wire
4days ago
IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the pharmaceutical and broader life sciences industry, today announces the first life sciences industry collaboration with Alibaba Cloud in China. IQVIA and Alibaba Cloud, the...
Business Wire
17days ago
The total spending and global demand for medicines will increase over the next five years to approximately $1.9 trillion by 2027, according to a new report titled Global Use of Medicines 2023 Outlook through 2027 from the IQVIA Institute for Human Data Science. The underlying growth rate of 3-6% in...
PR Newswire
1month ago
Lasso announces a significant step forward in healthcare marketing measurement Lasso announces a significant step forward in healthcare marketing measurement PR Newswire AUSTIN, Texas, Jan. 3, 2023 The healthcare marketing and analytics leader expands their Measurement Suite to include...
PR Newswire
1month ago
Biostage Selects IQVIA to Manage its FDA-Approved Clinical Trial in Severe Esophageal Disease, including Cancer Biostage Selects IQVIA to Manage its FDA-Approved Clinical Trial in Severe Esophageal Disease, including Cancer PR Newswire HOLLISTON, Mass., Dec. 28, 2022 IQVIA was selected because of...
Simply Wall St
1month ago
The recent price decline of 4.4% in IQVIA Holdings Inc.'s ( NYSE:IQV ) stock may have disappointed insiders who bought...
Frequently Asked Questions
Frequently Asked Questions
What is Iqvia Holdings Inc share price today?
plus_minus_icon
Can Indians buy Iqvia Holdings Inc shares?
plus_minus_icon
How can I buy Iqvia Holdings Inc shares from India?
plus_minus_icon
Can Fractional shares of Iqvia Holdings Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Iqvia Holdings Inc stocks?
plus_minus_icon
What is today’s traded volume of Iqvia Holdings Inc?
plus_minus_icon
What is today’s market capitalisation of Iqvia Holdings Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Iqvia Holdings Inc?
plus_minus_icon
What percentage is Iqvia Holdings Inc down from its 52-Week High?
plus_minus_icon
What percentage is Iqvia Holdings Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$237.18
$-3.47
(-1.44%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00